Teva faces EU antitrust probe over MS drug CopaxoneThe European Commission has formally opened an antitrust investigation into Teva, which will assess whether the pharma company Share XTeva faces EU antitrust probe over MS drug Copaxonehttps://pharmaphorum.com/news/teva-faces-eu-antitrust-probe-over-ms-drug-copaxone/
